Rick Casten has been with Cosette since 2022, and has over 30 years of experience in Pharmaceutical, Bio-Tech, Fortune 500 Consumer Products, and public accounting. Prior to joining Cosette, he served as Executive Vice-President and Chief Financial Officer of Baudax Bio., a pharmaceutical company focused on innovative products for acute care settings, where he led all financial aspects of implementing the company’s global corporate strategy. Prior to his time at Baudax, Rick served as Vice President of Finance, Controller and Treasurer at Lupin Pharmaceuticals, Inc., a transnational pharmaceutical company, where he managed Lupin’s U.S. accounting operations, cash management and operations, and overall financial reporting. Prior to Lupin, Rick served in roles of increasing responsibility at Endo International plc, a specialty pharmaceutical company, including Senior Director, Financial Planning and Analysis and Senior Director, Finance and Accounting. Prior to Endo, Rick served in various financial roles at Campbell Soup Company. Rick spent the initial ten years of his career in public accounting, primarily at Ernst & Young LLP, rising to Senior Manager, Assurance and Advisory Business Services.
He holds a B.S. in Business and Economics, with a major in Accounting, from Lehigh University and an M.B.A. from the Johnson School at Cornell University. Rick is a Certified Public Accountant in both Pennsylvania and California and is a member of the American Institute of Certified Public Accountants and the Pennsylvania Institute of Certified Public Accountants.
Cosette’s transformation has been driven primarily by strategic business development, operational excellence, and an unwavering focus on patients. By expanding our portfolio, strengthening our capabilities, and executing with discipline, we are creating long-term value while ensuring patients have continued access to the therapies they rely on.
